| Brannon Vines, | |
|
1717 6th Ave S, Birmingham, AL 35233-1801 | |
| (800) 822-8816 | |
| Not Available |
| Full Name | Brannon Vines |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 12 Years |
| Location | 1717 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477819738 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 33061 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Medical West, An Affiliate Of Uab Health System | Bessemer, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
The Bristol-Myers Squibb Foundation has awarded four new grants to help improve awareness, prevention and care of hepatitis B and hepatitis C in China and India.
Lesbian, gay, bisexual, transgender and queer (LGBTQ) patients who are also racial and ethnic minorities suffer significant health disparities, while facing more complicated challenges than white LGBTQ or racial and ethnic minority patients alone.
A parasite thought to be harmless and found in many people may actually be causing subtle changes in the brain, leading to suicide attempts.
Gloucester Pharmaceuticals announced today that ISTODAX® (romidepsin) has been included in the updated National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology™ as a suggested systemic treatment option for patients with mycosis fungoides and Sézary syndrome—two of the most common types of cutaneous T-cell lymphoma (CTCL).
› Verified 8 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
The Bristol-Myers Squibb Foundation has awarded four new grants to help improve awareness, prevention and care of hepatitis B and hepatitis C in China and India.
Lesbian, gay, bisexual, transgender and queer (LGBTQ) patients who are also racial and ethnic minorities suffer significant health disparities, while facing more complicated challenges than white LGBTQ or racial and ethnic minority patients alone.
A parasite thought to be harmless and found in many people may actually be causing subtle changes in the brain, leading to suicide attempts.
Gloucester Pharmaceuticals announced today that ISTODAX® (romidepsin) has been included in the updated National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology™ as a suggested systemic treatment option for patients with mycosis fungoides and Sézary syndrome—two of the most common types of cutaneous T-cell lymphoma (CTCL).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brannon Vines, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: () - | Brannon Vines, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: (800) 822-8816 |
News Archive
The Bristol-Myers Squibb Foundation has awarded four new grants to help improve awareness, prevention and care of hepatitis B and hepatitis C in China and India.
Lesbian, gay, bisexual, transgender and queer (LGBTQ) patients who are also racial and ethnic minorities suffer significant health disparities, while facing more complicated challenges than white LGBTQ or racial and ethnic minority patients alone.
A parasite thought to be harmless and found in many people may actually be causing subtle changes in the brain, leading to suicide attempts.
Gloucester Pharmaceuticals announced today that ISTODAX® (romidepsin) has been included in the updated National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology™ as a suggested systemic treatment option for patients with mycosis fungoides and Sézary syndrome—two of the most common types of cutaneous T-cell lymphoma (CTCL).
› Verified 8 days ago
Rayford W Thweatt, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Marla B Morgan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Robins J Newton, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2700 10th Ave S Ste 400, Birmingham, AL 35205 Phone: 205-918-0507 Fax: 205-930-2716 | |
Mohamed Kazamel, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Dr. Rodney K Swillie, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3686 Grandview Pkwy Ste 600, Birmingham, AL 35243 Phone: 205-971-3600 Fax: 844-772-0468 | |
Sandra L Frazier, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 619 19t Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Michael Alonzo Lopez, M.D., PH.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1600 6th Ave S # Chb314, Birmingham, AL 35233 Phone: 205-996-7850 |